Dr Carol Eileen Kleback, MD | |
108 Cowpath Rd, Suite 1, Lansdale, PA 19446-1152 | |
(215) 855-1599 | |
(215) 855-1589 |
Full Name | Dr Carol Eileen Kleback |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 108 Cowpath Rd, Lansdale, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073513503 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | MD417359 (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Carol Eileen Kleback, MD 123 Summer Ridge Dr, Lansdale, PA 19446-6709 Ph: (215) 361-3845 | Dr Carol Eileen Kleback, MD 108 Cowpath Rd, Suite 1, Lansdale, PA 19446-1152 Ph: (215) 855-1599 |
News Archive
The Ikerbasque researcher Koen Vandenbroeck, who heads the Neurogenomiks laboratory which reports to the Achucarro centre and the UPV/EHU-University of the Basque Country, together with other national and international groups, has shown that a genetic variant in the 5q11 chromosome, which is associated with susceptibility to developing multiple sclerosis, greatly regulates a gene known as ANKRD55. ANKRD55 is a gene with an unknown function.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Bupropion Hydrochloride Extended-Release Tablets USP, (SR), 100 mg, 150 mg and 200 mg, the generic version of GlaxoSmithKline's antidepressant Wellbutrin SR®.
Chronix Biomedical today announced that it will launch a new disease detection and monitoring service for cancer researchers at the upcoming 2010 ASCO Annual Meeting. The "For Investigational Use Only" laboratory-based testing service uses Chronix's breakthrough approach—the Chronix Apoptotic DNA Blood Test—which analyzes apoptotic DNA from dead and dying cells to identify and track ongoing changes associated with specific cancers and other chronic diseases.
A team of investigators at Brown University has developed a novel way to treat a class of breast cancer cells. The team has created twin nanoparticles that specifically targets the Her-2 tumor cell and unload a cancer-fighting drug directly into it. The result is a boost in antitumor activity while minimizing side effects. The findings of this study have been published in the Journal of the American Chemical Society.
› Verified 4 days ago
Rajni B Patel, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2031 N Broad St, Lansdale, PA 19446 Phone: 215-368-1114 Fax: 215-368-6608 | |
Dr. Susan D Ettinger, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 108 Cowpath Rd, Suite 1, Lansdale, PA 19446 Phone: 215-855-1599 Fax: 215-855-1589 | |
Elizabeth Walters, CRNP Pediatrics Medicare: Medicare Enrolled Practice Location: 108 Cowpath Rd Ste 1, Lansdale, PA 19446 Phone: 215-855-1599 | |
Jeanne Michelle Velasco, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1240 S Broad St Ste 130, Lansdale, PA 19446 Phone: 215-361-5040 | |
Bharati Bandyopadhyay, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2031 N Broad St, #145, Lansdale, PA 19446 Phone: 215-368-1114 Fax: 215-368-6608 | |
Rosanna C Spear, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 1240 S Broad St Ste 130, Lansdale, PA 19446 Phone: 215-361-5040 Fax: 215-393-5441 |